Preparation of Aseptic products

What is meant by supplying medicines "ready to use"?

It means providing medicines that are prepared and presented in a form that can be administered directly to the patient, without further manipulation.
Keywords: ready to use, administration, prepared, patient.

Why is it important to supply medicines of appropriate quality?

Medicines must meet quality standards to ensure they are safe and effective for the patient. Poor-quality medicines can cause harm or reduce treatment effectiveness.

What microbiological or particulate hazards must be avoided when supplying medicines, especially IV products?

Medicines, particularly intravenous (IV) products, must not contain microbes or particles that could harm the patient. IV products must be particle-free.
Keywords: microbiological hazard, particulate hazard, IV products, particle-free.

How can efficiency savings be achieved in the supply of medicines?

Efficiency savings can be achieved by using part vials safely, as recommended in the NHS Carter report, reducing waste and cost.
Keywords: efficiency savings, part vials, NHS Carter report, reduce waste.

How does optimising medicine supply help healthcare resources?

It decreases nursing time, allowing staff to focus on patient care, which aligns with key NHS objectives.

How does optimising medicine supply improve patient care?

It allows options such as homecare, which can increase patient comfort, convenience, and adherence to treatment.

How is technical expertise used in the supply of medicines?

harmacists and healthcare professionals use technical expertise to provide stable preparations with appropriate presentation and formulation for safe administration.

hy must medicine supply remain within legal boundaries?

Supplying medicines outside legal boundaries can result in patient harm and legal consequences; healthcare professionals must follow regulations and professional guidelines.

How can pharmacy advise and supply medicines if a licensed pharmaceutical is not available?

Pharmacy can provide clinical advice and supply medicines via the most appropriate route even when a licensed pharmaceutical product is not available, ensuring the patient still receives necessary treatment.

Why might patients who are nil by mouth require medicines via the parenteral route?

Patients who cannot take medicines orally need drugs administered via the parenteral route, which requires aseptic preparation to ensure the medicine is safe and effective

why do some drugs need to be given via an alternative route to the gut?

Some drugs are broken down by the gut before reaching their site of action, so they must be administered by a different route to be effective.

Why might some drugs be intentionally not absorbed by the gut?

Some drugs, like vancomycin capsules, are designed to act locally in the gut to kill bacteria without being absorbed into the bloodstream.

What are some reasons a patient’s gut may not function properly, requiring an alternative route of administration?

Gut dysfunction may occur after gut surgery, in premature babies whose digestive systems are not fully developed, or due to other medical conditions, necessitating administration by an alternative route.

How does first-pass metabolism affect drug administration?

Drugs that undergo first-pass metabolism are metabolized by the liver after being absorbed through the gut before reaching their target site. Administering such drugs via an alternative route can prevent early metabolism and improve efficacy.

How can local administration of a drug reduce side effects or increase concentration at the target site?

Drugs can be delivered directly to a local site, such as the eye for ocular treatment or into a joint or spine for pain control, which can enhance efficacy and reduce systemic side effects.

Why might parenteral drug routes be preferred over traditional enteral routes in emergency situations?

Parenteral routes can act faster than oral administration, which is critical in emergencies like epilepsy or cardiac arrest where rapid drug action is required.

What risk assessment and precautions are pharmacies required to take for high-risk aseptic products on the ward?

: Pharmacies must follow NPSA alerts to risk assess ward drug preparation activities. High-risk aseptic products should be removed from near-patient areas. This includes:

• Items with open systems (e.g., multidose ampoules)

• Hazardous drugs like chemotherapy, radiopharmaceuticals, and penicillin-based antibiotics

• Parenteral nutrition requiring multiple additions (up to 40)

• Infusions lasting longer than 24 hours, which could allow bacterial growth if contaminated

What additional factors increase risk when preparing medicines on the ward, and how should they be managed?

Risks increase with:

• Drugs that need mixing, due to potential stability and compatibility issues (two drugs not precipitating does not guarantee stability)

• Unfamiliar processes, which require expertise
  Pharmacy staff should prepare these high-risk or unfamiliar products to ensure safety and stability.

How can patient factors impact the final medicine product supplied?

Patient factors such as the recipient’s health, immune system status, age (neonates, children, elderly), intensive therapy or trauma, and immunosuppression can affect how medicines are formulated and administered. Positive factors, like a transplant patient’s drug therapy, and negative factors, like chemotherapy side effects, must also be considered.

hat special considerations may pharmacy need to make when preparing medicines for individual patients?

harmacy may need to:

• Prepare very small doses requiring double dilutions

• Adjust for fluid restrictions (e.g., a premature neonate limited to 100 mL/day)

• Combine multiple drugs in a single infusion bag if the patient has limited venous access
  These measures ensure the final product meets the patient’s clinical needs safely and effectively.

How do presentations of starting materials affect the complexity of drug preparation?

The form of the starting material influences how easy or difficult it is to prepare the final product. Solutions are generally easier to handle, while powders, emulsions, and suspensions require more manipulations and calculations, increasing preparation complexity.

What are the advantages and risks of using solutions as starting materials?

Solutions are easier to handle and less hazardous from a health and safety perspective. However, they are more susceptible to oxidation, hydrolysis, and microbial degradation, which can reduce stability and effectiveness.

What challenges are associated with powders in drug preparation?

Powders require additional aseptic manipulations, careful calculations to ensure correct dosing, and proper diluent selection. Errors in these steps can affect stability, reduce dissolution, increase particulates, and potentially harm the patient

When are emulsions and suspensions used, and what special considerations do they require?

Emulsions and suspensions are used rarely. They require strictly controlled particle sizes and are often restricted to specific routes of administration, such as subcutaneous (SC), intramuscular (IM), or intrathecal (IT), to ensure safety and efficacy.

SC=into the skin
IM= into the muscle
IT= into cerebrospinal fluid.

: How does drug concentration affect formulation and dosing?

Drug concentration determines how much of the active drug is in the solution. It must be correct to ensure the patient receives the right dose. The required volume and any infusion bag overage also affect concentration calculations.

What is solubility, and how can it be maintained in a formulation?

Solubility is a drug’s ability to dissolve in a solution. Some drugs require co-solvents, surfactants, or buffers to stay dissolved and stable in the final product.

How does physical stability affect drug formulation?

Physical stability ensures the drug does not break down or form particles. Factors like vibration or movement of the infusion bag can affect stability and potentially harm the patient if not controlled.

What is tonicity, and why is it important in formulations?

Tonicity is the salt concentration of a solution compared to body fluids. Ideally, drugs are formulated to be isotonic, matching blood concentration, to avoid irritation or damage when administered.

What can happen if a parenteral solution is not isotonic when administered to a patient?

If a solution is hypertonic (higher solute concentration than body fluids), it can cause cells to shrink (crenation) and may irritate veins or tissues. If a solution is hypotonic (lower solute concentration), cells can swell and even burst (lysis). This is why isotonic solutions are preferred for intravenous administration.

: How do pharmacists adjust formulations to achieve isotonicity?

Pharmacists can adjust isotonicity by adding salts (e.g., sodium chloride) or sugars (e.g., glucose) to match the osmolarity of body fluids. They must calculate carefully to avoid over- or under-correction, ensuring the final product is safe and comfortable for the patient.

How does pH affect drug stability?

Drugs are generally more soluble when ionized, but this can also increase degradation. For example, erythromycin is stable for 20 days at pH <6.5 but remains stable for 65 days at pH >6.5. Adjusting pH can therefore improve shelf-life.

How does the physical form of a drug influence its stability?

Solid forms, like powders or suspensions, can reduce degradation such as hydrolysis. For example, subcutaneous azacitidine is supplied as a powder to be diluted into a suspension, which helps preserve stability compared to a solution.

How can catalysts affect drug degradation?

Catalysts can accelerate drug breakdown. For instance, carboplatin in glucose has a 42-day shelf life, whereas in saline it degrades in 24 hours due to chlorine in the diluent acting as a catalyst.

Why is the choice of diluent important for drug stability?

Diluents can impact chemical and physical stability. Monoclonal antibodies (mAbs), for example, can be damaged by glucose, which glycates the antibody, reducing bioactivity and molecular stability.

How does light exposure impact drugs during preparation or storage?

Light can degrade drugs and sometimes produce toxic products. Dacarbazine, for example, forms a toxic degradation product when exposed to light, making protection from light critical during preparation and storage.

How does storage temperature affect drug stability?

Refrigeration generally slows chemical reactions and microbial growth, but it can also reduce solubility. For example, 5-FU at 50 mg/mL will precipitate in the fridge, while 25 mg/mL remains in solution.

How do solutions and solids differ in terms of drug degradation risk?

Solutions are more prone to chemical degradation like hydrolysis, while solid forms or suspensions tend to be more stable because less water is available to promote these reactions.

Give an example of how drug formulation must consider multiple stability factors.

Carboplatin’s stability depends on the diluent (chlorine as a catalyst), pH, temperature, and light exposure. Pharmacists must consider all these factors to ensure safe and effective administration.

What does it mean that drugs are more stable when ionised?

When a drug is ionised (charged), it usually dissolves more easily in water, which can improve absorption. However, ionised drugs are also often more chemically reactive, which can make them less stable in solution. In contrast, non-ionised (neutral) drugs may be less soluble but degrade more slowly.

Simple analogy: Think of sugar vs. salt crystals. Salt dissolves quickly in water (like ionised drugs), but if the water is hot or acidic, it reacts faster.

Why do solid forms like powders or suspensions reduce hydrolysis and improve drug stability?

Hydrolysis is a reaction where water breaks down the drug. In solid forms, there is less water present, so there’s less opportunity for hydrolysis to happen. Suspensions or powders stay stable longer because the drug is mostly in a dry form until it’s dissolved for use.

What does it mean that glucose “glycates” monoclonal antibodies (mAbs)?

Glycation is a chemical reaction where sugar molecules, like glucose, attach to proteins (like mAbs). This can change the protein’s shape or interfere with its function, reducing its stability and bioactivity.

Why is the choice of container important for aseptic products?

An unsuitable container can compromise product quality. Issues include adsorption of drugs to the container, leaching of harmful plasticisers, permeability to oxygen, and moisture loss—all of which can reduce drug stability and effectiveness

How can adsorption and leaching affect drugs in containers?

Adsorption occurs when drugs stick to the container material, e.g., low-concentration insulin can lose potency in some plastics. Leaching happens when plasticisers (like phthalates in PVC) migrate into the solution, potentially causing toxicity, especially with lipid- or polysorbate-containing drugs.

How does container permeability or moisture loss impact drug stability?

containers that allow oxygen in can accelerate oxidative degradation (e.g., vitamin C). PVC containers can lose moisture over time (e.g., 10% in 3 months at room temperature), which can concentrate or destabilize drugs like morphine, affecting the dose delivered to patients.

Why must new attachments, filters, or accessories be carefully assessed before use with a drug product?

Additions like filters or in-line devices can compromise container integrity, allow microbial contamination, or interact with the drug. For example, liposome-based drugs can be filtered out, and some formulations may stick to the filter. Compatibility and safety must be assessed before use.

Q1: Why is PVC often unsuitable for aseptic drug products?

PVC can leach plasticisers such as DEHP, which may be harmful to patients. It also has a poor barrier to oxygen and can lose moisture, both of which can compromise drug stability.

What are the limitations of EVA as a container material?

EVA is compatible in that it does not leach plasticisers, but it has a poor oxygen barrier, which can allow oxidative degradation of sensitive drugs.

Why are multilayer containers considered ideal for drug products?

Multilayer containers provide a strong barrier to oxygen and moisture. This reduces oxidation reactions and prevents loss of ingredients, protecting drugs like ascorbic acid and amino acids.

How much better is a multilayer container at preventing oxidation compared to PVC or EVA?

Multilayer containers can be up to 100 times better at providing an oxygen barrier, greatly reducing oxidative degradation and maintaining drug stability.

What are the main components of ophthalmic solutions?

: Ophthalmic solutions can contain:

• pH buffers to maintain stability and comfort

• Preservatives to prevent microbial growth

• Antioxidants to prevent oxidation of the drug

• Viscosity enhancers to improve retention time on the eye

What pH range is used for ophthalmic solutions, and why is this important?

Ophthalmic solutions are buffered in a pH range of 4.5 to 11.5. Maintaining an appropriate pH ensures drug stability and reduces irritation to the eye.

Why is tonicity important in ophthalmic solutions?

Tonicity affects comfort and safety. Lacrimal fluid is iso-osmotic with 0.9% sodium chloride, but the eye can tolerate 0.6–1.8% NaCl equivalence. Solutions outside this range can cause irritation or damage.

points to remember:

• Ophthalmic solutions must be stable, safe, and comfortable.

• Key factors: pH, buffers, preservatives, antioxidants, viscosity, tonicity, and osmolarity.

• Eye tolerance is limited: pH ~4.5–11.5, osmolarity ~300 mOsm/L, NaCl 0.6–1.8%.

What volume restrictions are typical for subcutaneous, intramuscular, or intra-articular injections?

These routes are volume-restricted, ideally less than 2 mL per injection to prevent tissue damage and ensure patient comfort.

Are particulates acceptable in suspensions for these routes?

Yes, particulates are generally acceptable in suspensions for SC, IM, or intra-articular administration. For example, azacitidine is supplied as a particulate-containing suspension.

How can excipients be used to increase the administration volume for subcutaneous injections?

Excipients such as hyaluronidase can be added to enable administration of larger volumes, for example greater than 5 mL, by temporarily increasing tissue permeability.

Give an example of a drug where the use of a suspension and particulates is appropriate for SC administration.

Azacitidine suspension is an example where particulates in the formulation are acceptable for subcutaneous administration.

: What tonicity requirements apply for intravascular (IV) solutions?

IV solutions should generally be isotonic.

• Hypertonic solutions (>10% glucose) must be given via a central vein, while peripheral veins tolerate <10% glucose or very slow injections of small volumes.

• Hypotonic solutions can be optimized by adjusting the diluent.

What particle size requirements are important for intravascular preparations?

IV solutions must be particle-free, except in specialized cases like liposomes, which can be <3 μm in size.

How are excipients used in intravascular formulations?

excipients maintain drug solubility and stability. Common excipients include:

• Co-solvents to improve solubility

• Surfactants to prevent aggregation

• Buffers to maintain pH

Why must hypertonic solutions often be restricted to central veins or slow peripheral infusion?

Hypertonic solutions can cause irritation or damage to peripheral veins if administered in large volumes too quickly. Central veins are preferred because they dilute the solution faster and reduce tissue damage.

What tonicity is generally safest for IV drugs?

Isotonic (~300 mOsm/L), because it matches the body’s fluids and minimizes irritation or cell damage.

: When might hypertonic solutions be used in IV therapy?

Hypertonic solutions are used for drugs that require high solute concentrations, such as >10% glucose or certain electrolytes, when isotonic solutions are not feasible.

Why are hypertonic solutions usually given via a central vein?

The large blood flow in central veins quickly dilutes the solution, reducing irritation and the risk of tissue damage.

How can hypertonic solutions be safely administered in peripheral veins?

They must be lower concentration (<10% glucose) or infused slowly in small volumes to prevent vein irritation or damage.

Can hypotonic solutions be given intravenously?

Yes, but they must be carefully controlled because they can cause cell swelling or hemolysis if administered too quickly or in large volumes.

what does intrathecal administration mean?

intrathecal (IT) administration is injecting a drug directly into the cerebrospinal fluid (CSF), usually via the spinal canal. This delivers the drug directly to the central nervous system (CNS), bypassing the blood–brain barrier.

What does intravascular administration mean?

Intravascular administration is delivering a drug directly into the blood vessels, typically through:

• Intravenous (IV) injection or infusion into a vein

• Intra-arterial (rare) into an artery

This route allows the drug to rapidly circulate throughout the body.

Example: IV infusion of 5-FU for chemotherapy

What additives should be avoided in intrathecal (IT) formulations and why?

Antimicrobials, antioxidants, pyrogens, and preservatives should be avoided because they can be toxic to the central nervous system.

What do pharmacopoeias (E.P. & B.P.) specify for intrathecal injections?

: They specify that IT injections should not contain any other additives, and sodium chloride should be used as the tonicity-adjusting agent.

Are particulates acceptable in IT formulations? Give an example.

Yes, particulates can be acceptable. For example, baclofen microspheres are formulated as a slow-release IT preparation.

Why is the endotoxin limit lower for IT formulations compared to IV or IM products?

The CNS is very sensitive, so a lower endotoxin limit is required. Using IV or IM products for IT administration without adjusting for endotoxins may cause toxic reactions.

Why is documentation an essential part of GMP?

Documentation is mandatory in Good Manufacturing Practice (GMP) and is required by regulatory authorities. Without proper documentation, products cannot be released.

How does documentation support traceability?

Documentation provides batch traceability and a real-time record of what was happening during manufacturing at any point in time, which is critical for quality and accountability.

How does documentation contribute to consistency in pharmaceutical production?

Documentation defines the system and ensures that manufacturing processes are carried out consistently, reducing variability in the final product.

What other benefits does documentation provide in GMP?

Documentation supports and records effective training and reduces errors and misunderstandings that can arise from verbal communication.

What filters are

• Filters are physical barriers that remove unwanted particles or microorganisms from a solution during drug formulation.

• They come in different sizes depending on the purpose:

  • 5 micron filters → remove visible particulates

  • 0.2 micron filters → sterilising filters, remove bacteria and most microorganisms

Why filters are used

• Removal of particulates → ensures patient safety by preventing injection of particles that could block blood vessels or cause irritation.

• Sterilisation → removes bacteria to make the solution safe for injection.

• Order of addition (wetting the filter) → ensures the filter works properly and prevents air bubbles or channeling.

• Compatibility checks → filters can interact with the drug or formulation, so you must make sure they don’t:

  • Adsorb the drug → reduce the dose delivered

  • Destabilise the formulation → cause precipitation, aggregation, or chemical changes

Q3: Why must the order of addition and filter wetting be considered?

Proper order and wetting prevent air bubbles, ensure efficient filtration, and maintain filter performance.

Why is filter compatibility important in drug formulation?

Incompatible filters can adsorb the drug (reducing dose) or destabilise the formulation (causing precipitation, aggregation, or chemical changes).